Ensysce Biosciences (ENSC) Preferred Shares (2020 - 2025)

Ensysce Biosciences (ENSC) has reported Preferred Shares for 4 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Preferred Shares rose 142.37% year-over-year to $3.6 million in Q4 2025; TTM through Dec 2025 was $3.6 million, a 142.37% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 142.37% from the prior year.
• Preferred Shares was $3.6 million for Q4 2025 at Ensysce Biosciences, up from $1.5 million in the prior quarter.
• Over five years, Preferred Shares peaked at $3.6 million in Q4 2025 and troughed at $1.5 million in Q2 2021.
• A 3-year average of $2.2 million and a median of $1.5 million in 2021 frame the typical range for Preferred Shares.
• Across the five-year window, Preferred Shares soared 1400.0% in 2021 and jumped 142.37% in 2025, its largest moves.
• Over 3 years, Preferred Shares stood at $1.5 million in 2021, then changed by 0.0% to $1.5 million in 2024, then jumped by 142.37% to $3.6 million in 2025.
• The last three Preferred Shares figures came in at $3.6 million (Q4 2025), $1.5 million (Q4 2024), and $1.5 million (Q2 2021), per Business Quant data.